The operating profit of Black Spade-U turned negative in Q3 2024, primarily due to Increased Expenses and Decreased Revenue1.
The company's financial results were impacted by several key factors:
- Cost Management Issues: There was a significant increase in operating expenses, which adversely affected the company's profitability. This was likely due to higher costs associated with operations, research and development, or sales and marketing efforts that were not adequately matched by revenue growth.
- Revenue Decline: Despite strong adoption of Nodify tests, the overall revenue growth was insufficient to offset the increased expenses. This could be attributed to lower-than-expected sales from other diagnostic services or disruptions from Hurricane Helene, which may have impacted the availability and demand for certain tests.
In summary, the negative operating profit was a result of an imbalance between rising expenses and stagnant revenue growth, leading to a notable decline in profitability for the period.